Published in TB and Outbreaks Week, October 23rd, 2001
Transgenomic also announced that its technology is being used by leading defense contractors to develop protocols for the rapid detection of biological agents that may be used in an attack by terrorists.
Based on the successful application of WAVE technology for the identification of agents likely to be used in a bioterrorist attack, multiple unit placements of the WAVE DNA analyzer have been made at leading U.S....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.